HURN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Buy now: price (~165) is sitting close to first support (S1 ~160.85) with RSI(6) near oversold, which often sets up a tradable rebound even while the broader trend is soft.", "Wall Street is firmly constructive: multiple recent Buy ratings with large price-target step-ups ($215 and $240), implying meaningful upside vs. the current price.", "Fundamentals support the bull case (Q3\u201925 double-digit revenue and EPS growth), and the next clear catalyst is earnings on 2026-02-26 (after hours).", "Intellectia Proprietary Trading Signals\n- AI Stock Picker: No signal on given stock today.\n- SwingMax: No signal on given stock recently."]
["Trend/tone: short-term bearish-to-neutral; moving averages are converging (loss of clear trend, often a transition phase).", "Momentum: MACD histogram is negative (-1.447) but negatively contracting (downtrend pressure is easing, consistent with a potential bounce setup).", "RSI(6): 31.27 (near oversold zone), supporting a rebound attempt rather than fresh downside momentum.", "Key levels: Pivot 169.14 is the first reclaim level; above it, resistance at 177.44 then 182.56. Support sits at 160.85 then 155.73.", "Near-term pattern stats: model suggests modest positive drift (about +0.37% next day, +1.55% next week, +2.08% next month)."]
["Earnings catalyst ahead: QDEC 2025 earnings on 2026-02-26 (after hours) with Street EPS est. ~1.94.", "Analyst conviction rising: Truist and Benchmark both reiterated Buy while sharply raising price targets, signaling improving confidence in forward growth visibility.", "Technical setup for a bounce: near-oversold RSI and easing negative MACD momentum near support."]
fails, next downside reference is ~155.73.", "Margin pressure: gross margin dipped slightly YoY (31.18%, down ~0.42 pts), which can cap near-term multiple expansion if it persists.", "No fresh news flow in the past week: fewer near-term narrative catalysts until earnings."]
["Latest quarter: 2025/Q3.", "Revenue: $432.36M (+16.84% YoY) \u2014 strong top-line growth.", "Net income: $30.42M (+12.05% YoY) \u2014 earnings growing, but slower than revenue.", "EPS: $1.71 (+16.33% YoY) \u2014 solid per-share growth.", "Profitability: gross margin 31.18% (down ~0.42 pts YoY) \u2014 mild compression to monitor."]
["Recent trend: price targets have been moving up materially while Buy ratings were maintained.", "2025-11-14: Truist raised PT to $240 from $180; kept Buy; cited \u201chigh conviction in accelerating growth\u201d and increased valuation multiple assumption.", "2025-12-24: Benchmark raised PT to $215 from $180; kept Buy; cited improved visibility and improving organic growth curve into 2026+.", "Wall Street pros: accelerating growth narrative, better forward visibility, continued Buy support with higher targets.", "Wall Street cons: part of the upside case depends on multiple expansion and sustained execution; any ongoing margin compression could temper enthusiasm."]
